Pediatric Dermatology News

 
 
  • Impax Reaches $20 Mln Deal to End Trial Over Generic Drug's Delay Impax Laboratories Inc has agreed to pay $20 million to consumers and insurers to resolve claims that the drugmaker entered an anticompetitive deal to delay launching a generic, cheaper version of acne medication Solodyn.
  • Dermira to Abandon Acne Drug, Shares Crater Dermira Inc will discontinue development of its acne drug after the treatment failed to meet the main goals of two late-stage studies, the company said on Monday.
  • AADOral Eczema Treatments Generate Excitement Impressive phase 2 results raise hope that oral medications will replace injections for atopic dermatitis.
  • Depression Risk Rises With New Acne Diagnosis In the first year after a new diagnosis of acne, patients’ risk for a diagnosis of major depressive disorder spikes by more than 60 percent compared to the general population, a new study shows.
  • AADAcne Can Be More Distressing Than Melanoma Inflammatory skin diseases cause more harm than skin cancers when years of disability are considered, according to the latest report from the Global Burden of Disease Study.
  • AADImmune Modulation in the Spotlight at AAD 2018 Immunomodulators for inflammatory diseases and cancer will be among the hot topics at the upcoming American Academy of Dermatology meeting.
  • French Families Plan to Sue Retailers Over Baby Milk Recall -Group Some French families are planning to take legal action against supermarket chains after potentially tainted products found their way onto shop shelves despite a recall, the spokesman of a victims' group said on Monday.
  • France's Lactalis Forced Into New Recall in Baby Milk Scare French dairy group Lactalis is widening a product recall to cover all baby milk manufactured by a factory at the center of a salmonella contamination, Finance minister Bruno Le Maire said on Friday.
  • French Retailers Sold Lactalis Baby Milk After Salmonella Recall France's biggest supermarket chains said they sold some Lactalis baby food products after a recall by the dairy giant over concerns they could be contaminated with salmonella.
  • Teledermatology Platform May Allow High-quality Acne Evaluation Patient-taken iPhone photos transmitted and stored in the Network Oriented Research Assistant (NORA) teledermatology program may be as useful for acne evaluations as in-person consultations, a pilot study suggests.
  • Teen Acne Tied to Prostate Cancer Risk Swedish researchers report an association between acne -- particularly severe acne -- in the late teen years and later prostate cancer risk, a finding that validates other research.
  • France Orders International Recall of Lactalis Baby Formula France has ordered banned the sale and ordered a recall of several baby formula milk and baby food products made by French dairy giant Lactalis after the discovery of Salmonella bacteria, consumer protection agency DGCCRF said in a statement.
  • Plain Water Baths as Effective as Bleach Baths for Eczema Bleach baths are no more effective for the treatment of eczema than plain water baths and may cause unpleasant adverse effects such as burning and stinging, a study found.
  • Smartphone Pics May Be Sharp Enough for Dermatology Diagnosis With a few exceptions, a dermatologist was just as accurate in diagnosing children’s skin conditions from smartphone photos taken by parents as the doctors who saw the kids in person, a small U.S. study found.
  • Prescription-Strength Steroid Creams Sold Without Prescription Although the U.S. requires prescriptions for topical steroids with more than a 0.5% concentration, much stronger and potentially harmful steroid creams are not hard to find without a prescription, doctors report.
  • ACAAIEczema Can Predict Severity of Asthma Hospitalization A family history of asthma and a patient's own history of atopic dermatitis are linked to a more severe hospital experience, according to a study that could influence care decisions.
  • ACAAINew Drugs for Atopic Dermatitis Boost Treatment Options For decades there were few options for people with atopic dermatitis, but new choices, with more in the pipeline, have meant a substantial shift in treatment.
  • Dermatology Guideline Authors Take Big Payments From Industry Dermatology clinical practice guideline authors often receive large payments from industry and don't always fully disclose them, researchers report.
  • ACAAIFood Introduction, Chronic Cough Top Allergy Meeting Lineup The challenge of explaining updated guidelines on the introduction of peanut products will be among the topics addressed at the American College of Allergy, Asthma & Immunology (ACAAI) meeting.
  • Lilly/Incyte Pill Beats Placebo in Mid-stage Eczema Trial Eli Lilly and Co and Incyte Corp on Thursday said a mid-stage trial of their oral drug baricitinib showed that at the highest dose it worked better than placebo for people with moderate-to-severe atopic dermatitis.